NASDAQ:TLPH

Talphera (TLPH) Stock Price, News & Analysis

$1.05
-0.07 (-6.25%)
(As of 04/26/2024 ET)
Today's Range
$1.02
$1.08
50-Day Range
$0.93
$1.50
52-Week Range
$0.43
$1.61
Volume
39,887 shs
Average Volume
119,048 shs
Market Capitalization
$17.82 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.00

Talphera MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
471.4% Upside
$6.00 Price Target
Short Interest
Healthy
0.65% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.00mentions of Talphera in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.12) to ($1.06) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.87 out of 5 stars

Medical Sector

598th out of 913 stocks

Drug Manufacturers - Specialty & Generic Industry

1st out of 1 stocks

TLPH stock logo

About Talphera Stock (NASDAQ:TLPH)

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is headquartered in San Mateo, California.

TLPH Stock Price History

TLPH Stock News Headlines

Talphera, Inc. (TLPH)
Talphera (NASDAQ:TLPH) Stock Price Up 1.7%
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.
Exposed: 10 CENT Crypto to Explode April 20th?
The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…
Week Ahead: Central Banks
See More Headlines
Receive TLPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Talphera and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/06/2024
Today
4/27/2024
Next Earnings (Estimated)
5/08/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
NASDAQ:TLPH
Previous Symbol
NASDAQ:TLPH
Employees
15
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$6.00
High Stock Price Target
$6.00
Low Stock Price Target
$6.00
Potential Upside/Downside
+471.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-18,400,000.00
Pretax Margin
-1,580.18%

Debt

Sales & Book Value

Annual Sales
$650,000.00
Book Value
$0.83 per share

Miscellaneous

Free Float
16,460,000
Market Cap
$17.82 million
Optionable
Optionable
Beta
0.51
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Mr. Vincent J. Angotti (Age 56)
    CEO & Director
    Comp: $906.54k
  • Dr. Pamela Pierce Palmer M.D. (Age 61)
    Ph.D., Co-Founder & Chief Medical Officer
    Comp: $699.75k
  • Mr. Raffi Mark Asadorian (Age 55)
    Chief Financial Officer
    Comp: $637.5k
  • Mr. Anil N. Dasu (Age 61)
    Chief Engineering Officer
    Comp: $478.09k

TLPH Stock Analysis - Frequently Asked Questions

Should I buy or sell Talphera stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Talphera in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" TLPH shares.
View TLPH analyst ratings
or view top-rated stocks.

What is Talphera's stock price target for 2024?

1 Wall Street analysts have issued 12 month price objectives for Talphera's stock. Their TLPH share price targets range from $6.00 to $6.00. On average, they expect the company's stock price to reach $6.00 in the next twelve months. This suggests a possible upside of 471.4% from the stock's current price.
View analysts price targets for TLPH
or view top-rated stocks among Wall Street analysts.

How have TLPH shares performed in 2024?

Talphera's stock was trading at $0.7989 at the beginning of 2024. Since then, TLPH stock has increased by 31.4% and is now trading at $1.05.
View the best growth stocks for 2024 here
.

When is Talphera's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our TLPH earnings forecast
.

How were Talphera's earnings last quarter?

Talphera, Inc. (NASDAQ:TLPH) announced its quarterly earnings data on Wednesday, March, 6th. The company reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.24) by $0.01. The business earned $0.28 million during the quarter.

How do I buy shares of Talphera?

Shares of TLPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:TLPH) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners